✦ LIBER ✦

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

✍ Scribed by Keon Woo Park; Jin Seok Ahn; Young Suk Park; Jeeyun Lee; Jung Hoon Kang; Joon Oh Park; Ho Yeong Lim; Young-Hyuck Im; Won Ki Kang; Keunchil Park; Soon Il Lee

Publisher: Springer
Year: 2006
Tongue: English
Weight: 223 KB
Volume: 59
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0253-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of S-1, docetaxel and cis

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

✍ Yasushi Sato; Tetsuji Takayama; Tamotsu Sagawa; Yasuo Takahashi; Hiroyuki Ohnuma 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 187 KB

Phase II study of docetaxel and cisplati

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB

Phase I/II study of 3-week combination o

Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer

✍ Jae-Lyun Lee; Hye Jin Kang; Yoon-Koo Kang; Min-Hee Ryu; Heung Moon Chang; Tae-Wo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 420 KB

A phase II study of doxifluridine and do

A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer

✍ Takaki Yoshikawa; Akira Tsuburaya; Ken Shimada; Atsushi Sato; Makoto Takahashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

A phase II study of irinotecan and docet

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

✍ Sun Jin Sym; Heung Moon Chang; Hye Jin Kang; Sung Sook Lee; Min-Hee Ryu; Jae-Lyu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB